What Happened?
Baltimore, MD-based Glyscend Appointed Ashish Nimgaonkar as President and Chief Executive Officer
About the Company
Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway.
About the Person
Ashish Nimgaonkar is President and Chief Executive Officer at Glyscend. Previously, Ashish held various senior HR leadership roles in the industry.
Info Source
News
Short Profile